期刊文献+

负载表阿霉素乙酰普鲁兰纳米粒的制备及细胞摄取

Preparation of epirubicin-loaded pullulan acetate nanoparticles and uptake by KB cells
下载PDF
导出
摘要 ①目的探讨疏水性乙酰普鲁兰作为纳米药物载体负载表阿霉素的可行性。②方法采用溶剂扩散法制备负载表阿霉素的PA纳米粒,并对其形态、粒径、包封率、载药量、体外释药特征和细胞摄取进行研究。③结果载药PA纳米粒为球形,载药量随乙酰基取代度的增大而增加,药物体外累积释放量随乙酰基取代度增高及释放介质pH降低而加快;与KB细胞(口腔上皮癌细胞株)温育2h,纳米粒中药物主要位于细胞浆,而游离药物主要位于胞核。④结论溶剂扩散法制备负载表阿霉素的PA纳米粒包封率和载药量高,体外释药具有缓释制剂特征,并可被肿瘤内吞入细胞。 Objective To investigate the feasibility of pullulan acetate (PA) was prepared epirubicin - loaded PA nanoparticles. Methods The solvent diffusion method was used to prepare EPI - loaded PA nanoparticles. The nanoparticles were characterized in terms of morphology, particle size, drug loading, drug release profile and intracellular uptake. Results The drug - loaded PA nanoparticles were spherical. The drug entrapment and drug content increased as the degree of acetyl substitution increasing. The size of EPI - loaded PA nanoparticles increased with the increasing of EPI - loading content. The EPI release rate was controlled by the degree of substitution and pH of release medium. After 2h incubation, nanoparticle loading EPI mainly localized in the cytoplasm, whereas free EPI accumulated in nuclear. Conclusion The EPI - loaded PA nanoparticles have high entrapment efficiency and drug loading, and can retard drug release in vitro. The nanoparticles can be internalized by KB tumor cells.
出处 《河北联合大学学报(医学版)》 2012年第1期10-12,共3页 Journal of North China Coal Medical College
关键词 乙酰普鲁兰 纳米粒 表阿霉素 溶剂扩散 体外释药 Pullulan acetate. Nanoparticles. Epirubicin. Solvent diffusion. Drug release in vitro
  • 相关文献

参考文献1

二级参考文献11

  • 1KIMOTO T,SHIBUYA T,SHIOBARA S. Safety studies of a novel starch, pullMan:Chronic toxicity in rats and bacterial mutagenicity [ J ]. Food Chem Toxicol, 1997,35 ( 3-4 ) :323 - 329.
  • 2KAZUNARI A,SEIICHI K, SHOZO S,et al. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin [ J ]. J Control Release, 1998,54 ( 3 ) : 313 - 320.
  • 3JEONG Y, NA HS,OH JS,et al. Adriamycin release from self-assembling nanospheres of poly ( dl-laetide-co-glycolide )-grafted pullulan[J], lnt J Pharm,2006,322( 1-2 ) :154 -160.
  • 4NA K, LEE TB, PARK KH,et al. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor Ph:pH-dependent cell interaction,internalization and cytotoxicity in vitro[J]. Eur J Pharm Sci,2003,18(2):165-173.
  • 5JUNG SW,JEONG YI, KIM SH. Characterization of hydrophobized pullulan with various hydrophobicities [ J ]. Int J Pharm, 2003,254(1-2) :109 - 121.
  • 6NAOZUMI T,MITSUHIRO S. Synthesis and properties of pullulan acetate. Thermal properties, biodegradability, and a semiclear gel formation in organic solvents [ J ]. Carbohydr Polym, 2006,63(4) :476 -481.
  • 7HIDEKI M, MASAO K, HIROFUMI T, et al. Preparation of poly (DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method [ J]. Int J Pharm, 1999, 187(1-2) :143 - 152.
  • 8GALINDO-RODRIGUEZ S, ALLEMAAN E, FESSI H, et al. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods[ J ]. Pharm Res,2004,21 ( 8 ) : 1428 - 1439.
  • 9BILATIL U,ALLEMAAN E,DOELKER E. Development of a nanoprecipitatlon method intended for the entrapment of hydrophilic drugs into nanoparticles [ J ]. Eur J Pharm Sci, 2005,24 (1) :67 -75.
  • 10THIOUNE O, FESSI H, DEVISSAGUET JP,et al. Preparation of pseudolatex by nanoprecipitation: Influence of the solvent nature on intrinsic viscosity and interaction constant[ J]. Int J Pharm, 1997,146(1-2) :233 - 238.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部